Daclizumab

From WikiMD.org
Jump to navigation Jump to search
Daclizumab
TermDaclizumab
Short definitionDaclizumab - (pronounced) (duh-KLIH-zoo-mab) drug used to stop the body from rejecting kidney transplants. It is also being studied in the treatment of some cancers and other conditions. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Daclizumab - (pronounced) (duh-KLIH-zoo-mab) drug used to stop the body from rejecting kidney transplants. It is also being studied in the treatment of some cancers and other conditions. Daclizumab attaches to receptors for a protein called interleukin-2 found on some types of immune cells and cancer cells. This can help suppress the body's immune response and kill cancer cells. Daclizumab is a type of monoclonal antibody. Also called dacliximab and zenapax

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski